Director/PDMR Shareholding
13 November 2024
The Law Debenture Corporation p.l.c.
Notification of Transaction by a Person Discharging Managerial Responsibility
The Law Debenture Corporation p.l.c. (the "Corporation") announces that on 12 November 2024, Trish Houston reinvested dividends received from shares held on her own account, acquiring 18 ordinary shares of 5 pence each in the Corporation at 880.257 pence per share.
The relevant notification set out below is provided in accordance with the requirements of UK market abuse regulations.
1
| Details of the person discharging managerial responsibilities | ||||
a) | Name | Trish Houston | |||
2
| Reason for the notification | ||||
a) | Position/status | Chief Operating Officer | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | The Law Debenture Corporation p.l.c. | |||
b) | LEI | 2138006E39QX7XV6PP21 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 5 pence each | |||
Identification code | GB0031429219 | ||||
b)
| Nature of the transaction | Acquisition of shares by dividend reinvestment. The resultant total shares held by Trish Houston on her own account as at 12 November 2024 is 2,278. | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
880.257 pence per share | 18 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 18 | ||||
- Price | £158.45 | ||||
e) | Date of the transaction | 12 November 2024 | |||
f) | Place of the transaction | London Stock Exchange | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.